Bifidobacterium infantis and 2′-fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in mice

Author:

Luo YatingORCID,Zhang Yujie,Yang Yang,Wu Simou,Zhao Jincheng,Li Yun,Kang Xiaohong,Li Zhouyong,Chen Jianguo,Shen Xi,He Fang,Cheng RuyueORCID

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

American Dairy Science Association

Subject

Genetics,Animal Science and Zoology,Food Science

Reference66 articles.

1. Microbiota Supplementation with Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational Study;Alcon-Giner;Cell Rep. Med.,2020

2. Safety and efficacy of a probiotic-containing infant formula supplemented with 2′-fucosyllactose: a double-blind randomized controlled trial;Alliet;Nutr. J.,2022

3. ATP drives lamina propria T(H)17 cell differentiation;Atarashi;Nature,2008

4. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome;Bazanella;Am. J. Clin. Nutr.,2017

5. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells;Berod;Nat. Med.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3